Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccineGlobeNewsWire • 10/28/20
Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?The Motley Fool • 10/18/20
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they standMarket Watch • 10/14/20
British pharma giant GlaxoSmithKline tells staff to turn off contact-tracing app while at workCNBC • 10/07/20
Vir Biotech, GlaxoSmithKline Advance COVID-19 Antibody Treatment Into Global, Late-Stage TrialBenzinga • 10/06/20
Vir Biotechnology, GlaxoSmithKline Expanding Phase 3 Trials For Covid-19 TreatmentInvestors Business Daily • 10/06/20
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19GlobeNewsWire • 10/06/20
COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' SupercomputerBenzinga • 10/06/20
U.S. federal appeals court reinstates GSK’s £182 million ruling against Teva PharmaceuticalInvezz • 10/04/20